These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 34030619)

  • 1. Flavonoids, the Family of Plant-Derived Antioxidants Making Inroads into Novel Therapeutic Design Against Ionizing Radiation-Induced Oxidative Stress in Parkinson's Disease.
    Behl T; Kaur G; Sehgal A; Zengin G; Singh S; Ahmadi A; Bungau S
    Curr Neuropharmacol; 2022; 20(2):324-343. PubMed ID: 34030619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective Mechanisms of Flavonoids in Parkinson's Disease.
    Magalingam KB; Radhakrishnan AK; Haleagrahara N
    Oxid Med Cell Longev; 2015; 2015():314560. PubMed ID: 26576219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondria-targeted antioxidants for treatment of Parkinson's disease: preclinical and clinical outcomes.
    Jin H; Kanthasamy A; Ghosh A; Anantharam V; Kalyanaraman B; Kanthasamy AG
    Biochim Biophys Acta; 2014 Aug; 1842(8):1282-94. PubMed ID: 24060637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combating Parkinson's disease with plant-derived polyphenols: Targeting oxidative stress and neuroinflammation.
    Gahtani RM; Shoaib S; Hani U; Jayachithra R; Alomary MN; Chauhan W; Jahan R; Tufail S; Ansari MA
    Neurochem Int; 2024 Sep; 178():105798. PubMed ID: 38950626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative Stress and Dopaminergic Metabolism: A Major PD Pathogenic Mechanism and Basis of Potential Antioxidant Therapies.
    Rasool A; Manzoor R; Ullah K; Afzal R; Ul-Haq A; Imran H; Kaleem I; Akhtar T; Farrukh A; Hameed S; Bashir S
    CNS Neurol Disord Drug Targets; 2024; 23(7):852-864. PubMed ID: 37303175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abrogating Oxidative Stress as a Therapeutic Strategy Against Parkinson's Disease: A Mini Review of the Recent Advances on Natural Therapeutic Antioxidant and Neuroprotective Agents.
    Theofanous T; Kourti M
    Med Chem; 2022; 18(7):772-783. PubMed ID: 35249501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flavonoids as Therapeutic Agents in Alzheimer's and Parkinson's Diseases: A Systematic Review of Preclinical Evidences.
    de Andrade Teles RB; Diniz TC; Costa Pinto TC; de Oliveira Júnior RG; Gama E Silva M; de Lavor ÉM; Fernandes AWC; de Oliveira AP; de Almeida Ribeiro FPR; da Silva AAM; Cavalcante TCF; Quintans Júnior LJ; da Silva Almeida JRG
    Oxid Med Cell Longev; 2018; 2018():7043213. PubMed ID: 29861833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of cellular redox environment as a novel therapeutic strategy for Parkinson's disease.
    Deus CM; Teixeira J; Raimundo N; Tucci P; Borges F; Saso L; Oliveira PJ
    Eur J Clin Invest; 2022 Oct; 52(10):e13820. PubMed ID: 35638352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotection through flavonoid: Enhancement of the glyoxalase pathway.
    Frandsen JR; Narayanasamy P
    Redox Biol; 2018 Apr; 14():465-473. PubMed ID: 29080525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic effects of multifunctional tetramethylpyrazine nitrone on models of Parkinson's disease in vitro and in vivo.
    Guo B; Xu D; Duan H; Du J; Zhang Z; Lee SM; Wang Y
    Biol Pharm Bull; 2014; 37(2):274-85. PubMed ID: 24305623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondria-targeted peptide antioxidants: novel neuroprotective agents.
    Szeto HH
    AAPS J; 2006 Aug; 8(3):E521-31. PubMed ID: 17025271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Damage to dopaminergic neurons by oxidative stress in Parkinson's disease (Review).
    Guo JD; Zhao X; Li Y; Li GR; Liu XL
    Int J Mol Med; 2018 Apr; 41(4):1817-1825. PubMed ID: 29393357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NADPH oxidase 1-mediated oxidative stress leads to dopamine neuron death in Parkinson's disease.
    Choi DH; Cristóvão AC; Guhathakurta S; Lee J; Joh TH; Beal MF; Kim YS
    Antioxid Redox Signal; 2012 May; 16(10):1033-45. PubMed ID: 22098189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of reactive oxygen species and genetic mitochondrial mutations in Parkinson's disease.
    Zuo L; Motherwell MS
    Gene; 2013 Dec; 532(1):18-23. PubMed ID: 23954870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do Naturally Occurring Antioxidants Protect Against Neurodegeneration of the Dopaminergic System? A Systematic Revision in Animal Models of Parkinson's Disease.
    Costas C; Faro LRF
    Curr Neuropharmacol; 2022; 20(2):432-459. PubMed ID: 33882808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antioxidants as therapy for Parkinson's disease.
    Shults CW
    Antioxid Redox Signal; 2005; 7(5-6):694-700. PubMed ID: 15890014
    [No Abstract]   [Full Text] [Related]  

  • 17. Neuroprotective potential of chrysin in Parkinson's disease: Molecular mechanisms and clinical implications.
    Angelopoulou E; Pyrgelis ES; Piperi C
    Neurochem Int; 2020 Jan; 132():104612. PubMed ID: 31785348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis of Neurodegenerative Diseases and the Protective Role of Natural Bioactive Components.
    Samanta S; Chakraborty S; Bagchi D
    J Am Nutr Assoc; 2024 Jan; 43(1):20-32. PubMed ID: 37186678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The contributions of antioxidant activity of lipoic acid in reducing neurogenerative progression of Parkinson's disease: a review.
    De Araújo DP; Lobato Rde F; Cavalcanti JR; Sampaio LR; Araújo PV; Silva MC; Neves KR; Fonteles MM; Sousa FC; Vasconcelos SM
    Int J Neurosci; 2011 Feb; 121(2):51-7. PubMed ID: 21126109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction-oxidation (redox) system in radiation-induced normal tissue injury: molecular mechanisms and implications in radiation therapeutics.
    Yahyapour R; Motevaseli E; Rezaeyan A; Abdollahi H; Farhood B; Cheki M; Rezapoor S; Shabeeb D; Musa AE; Najafi M; Villa V
    Clin Transl Oncol; 2018 Aug; 20(8):975-988. PubMed ID: 29318449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.